| secukinumab [Cosentyx, Zafrez] | Novartis | 2015 | 2015 | 2014 |
| brodalumab [Siliq, Lumicef, and Kyntheum] | AZ/Valeant | 2017 | 2017 | 2016 |
| ixekizumab [Taltz] | Eli Lilly | 2016 | 2016 | 2016 |